Higher HIV-1 DNA associated with lower gains in CD4 cell count among patients with advanced therapeutic failure receiving optimized treatment (ANRS 123—ETOILE).

Authors :: Avettand-Fenoel, Véronique
Bouteloup, Vincent
Mélard, Adeline
Fagard, Catherine
Chaix, Marie-Laure
Leclercq, Pascale
Chêne, Geneviève
Viard, Jean-Paul
Rouzioux, Christine
Source :: Journal of Antimicrobial Chemotherapy (JAC); Oct2010, Vol. 65 Issue 10, p2212-2214, 3p, 1 Graph
Publication Year :: 2010
Abstract: Objective: To describe HIV-1 DNA levels from baseline (W0) to week 52 (W52) among patients receiving either interleukin-2 (IL-2) + optimized background therapy (OBT) or OBT as salvage treatment. [ABSTRACT FROM PUBLISHER]

Full Text Access

Tools